Table I. Subject demographics
GenderAgeCD3 (cell/μl)IgG (mg/ml)IgA (mg/ml)IgM (mg/ml)Other
CVID 1M32111863<25<12.5
CVID2F271028NANANA
CVID 3M24237323.70.7Splenomegaly, chronic diarrhea
CVID 4F2511724402.83.4
CVID 5F3115232730.663.8Chronic diarrhea
CVID 6F31218459<25167.7
CVID 7F6NANANANA
CVID 8F311843<300<50<25Splenomegaly
CVID 9M412480<300<50< 25
CVID 10F402985<300<50< 25
CVID 11F341092<300<5033.1Vitiligo
CVID 12M34114898<50<25Celiac disease, splenomegaly
CVID 13F5110778644Atrophic gastritis
CVID 14F35262379<5025.9
CVID 15M6278169<50<25Esophagus cancer
CTRL 1M28911NANANA
CTRL 2F251678NANANA
CTRL 3M36NANANANA
CTRL 4M362226NANANA
CTRL 5M301991NANANA
CTRL 6F412003NANANA
CTRL 7F281695NANANA
CTRL 8F31877NANANA
CTRL 9F331407NANANA
CTRL 10F381912NANANA
CTRL 11M591652NANANA
CTRL 12F631932NANANA
CTRL 13F641254NANANA
CTRL 14F171763NANANA
CTRL 15F351712NANANA
CTRL 16M45NANANANA
CTRL 17F25NANANANA
CTRL 18M214420NANANA
CTRL 19M374938NANANA
CTRL 20F331875NANANA
CTRL 21F331428NANANA
CTRL 22F301330NANANA
  • CTRL, control; F, female; M, male; NA, not available.